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ABSTRACT 14 
The kinetics of decomposition of the pharmaceutical ranitidine (a major precursor of NDMA) during 15 
chloramination was investigated and some decomposition by-products were identified by using high 16 
performance liquid chromatography coupled with mass spectrometry (HPLC-MS). The reaction between 17 
monochloramine and ranitidine followed second order kinetics and was acid-catalyzed. Decomposition 18 
of ranitidine formed different by-products depending on the applied monochloramine concentration. 19 
 
2 
Most identified products were chlorinated and hydroxylated analogues of ranitidine. In excess of 20 
monochloramine, nucleophilic substitution between ranitidine and monochloramine led to by-products 21 
that are critical intermediates involved in the formation of NDMA, e.g. a carbocation formed from the 22 
decomposition of the methylfuran moiety of ranitidine. A complete mechanism is proposed to explain 23 
the high formation yield of NDMA from chloramination of ranitidine. These results are of great 24 
importance to understand the formation of NDMA by chloramination of tertiary amines. 25 
KEYWORDS  26 
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Introduction 28 
Nitrosamines, especially N-nitrosodimethylamine (NDMA), form during disinfection of drinking 29 
waters at near nanogram per liter levels1 or wastewaters at concentrations up to several hundred ng/L.2 30 
They are considered as probable human carcinogens by the US Environmental Protection Agency,3 and 31 
are listed in the USEPA’s Contaminant Candidate List 3.4 They can be formed in the presence of nitrites 32 
and free chlorine (HOCl-enhanced nitrosation) but are preferentially formed during chloramines 33 
disinfection.5 Over the last decade, several formation mechanisms have been proposed to explain 34 
NDMA formation by chloramination of secondary and tertiary amines. Most of them involve a 35 
nucleophilic substitution between dimethylamine (DMA) and monochloramine (NH2Cl) to form an 36 
Unsymmetrical Dimethylhydrazine intermediate (UDMH).6,7 Dichloramine (NHCl2) was proposed to 37 
favor the production of NDMA, through the formation of a chlorinated UDMH (UDMH-Cl) 38 
intermediate instead of UDMH.8 In the presence of bromide ion, it has been suggested that a brominated 39 
UDMH (UDMH-Br) would probably be formed.9,10 These intermediates were never detected during 40 
experiments because they are expected to be rapidly oxidized to NDMA. 41 
The contribution of tertiary amines to the production of substantial amounts of NDMA during 42 
chloramination has been pointed out.2,11,12 In particular, the pharmaceutical ranitidine has been 43 
demonstrated to produce high yields of NDMA (> 60%).11-13 Ranitidine is a histamine H2-receptor 44 
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antagonist used in treatment of peptic ulcer diseases, and was one of the most prescribed drug in the 80s. 45 
It has been progressively superseded by proton pump inhibitors, but it still remains in the top 15 sold-list 46 
of prescribed drugs in different European countries.14 Ranitidine has been detected in European and US 47 
wastewaters at concentrations ranging from 220 ng/L to 550 ng/L.15,16 Such high concentrations in 48 
wastewaters could explain the important NDMA formation potentials of wastewaters as compared to 49 
model waters containing similar amounts of DMA,2 because of the higher conversion rate of ranitidine 50 
in NDMA (> 60% as compared to < 3% for DMA).11,13 The presence of a pool of tertiary and quaternary 51 
amines acting as NDMA precursors (e.g., pesticides, pharmaceuticals and personal care products) could 52 
also participate in the overall NDMA yields observed in wastewaters.13,17 Ranitidine has been identified 53 
in surface waters of Italy at concentrations ranging from 1 to 10 ng/L,18,19 and has been detected in 1.2% 54 
of US streams at 0.01 µg/L.20 Several studies have addressed the photochemical degradation of 55 
ranitidine in the environment.21,22 Several photodecomposition products of ranitidine have been 56 
identified, but the by-products formed during the reaction between ranitidine and common oxidants used 57 
in water treatment (e.g., chlorine, monochloramine or ozone) have not been investigated.  58 
Many kinetic studies have addressed chlorine reactivity with model compounds but the reactivity of 59 
monochloramine with simple model compounds is not well documented.23 NDMA formation kinetics of 60 
some tertiary amines (i.e., ranitidine, chlorphenamine and doxylamine) have been recently investigated 61 
in various matrices.24 In this study, real water matrices had a significant impact on NDMA formation 62 
kinetics, especially leading to an initial lag period because of competitive reactions between natural 63 
organic matter (NOM) and tertiary amines. Studies about the decomposition kinetics of NDMA 64 
precursors such as anthropogenic tertiary amines are lacking. Moreover, potential intermediate species 65 
involved in the formation of NDMA remain unidentified. 66 
The aim of this study was to investigate the kinetics of decomposition of ranitidine by chloramination 67 
and to identify its decomposition by-products by using high performance liquid chromatography coupled 68 
with mass spectrometry (HPLC-MS). Reactions were conducted in deionized water to determine the 69 
kinetic constants for the reaction between monochloramine and ranitidine in pure solutions; hence 70 
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potential competitive effects of NOM with ranitidine were not studied. The identification of the reaction 71 
by-products should be useful to determine nucleophilic or electrophilic substitution sites in order to 72 
better understand the reaction mechanisms leading to the formation of NDMA by chloramination of 73 
ranitidine.  74 
 75 
Materials and Methods 76 
Materials. All experiments were conducted using deionized water (Milli-Q, Millipore) buffered with 77 
sodium acetate (pH = 4.0-5.5), a mixture of sodium phosphate monobasic and sodium phosphate dibasic 78 
(pH = 7.0-8.5), or sodium carbonate (pH = 10). pH values were adjusted as needed using sodium 79 
hydroxide or sulfuric acid (0.1 N, Fisher Scientific). Ranitidine was supplied through Sigma-Aldrich and 80 
was used without further purification. All other reagents were reagent grade or described previously.13 81 
All glassware used was washed with deionized water and baked at 500 °C for at least 5 hours prior to 82 
use. 83 
Experimental Methods. Preparation of monochloramine stock solutions was previously described,13 84 
and is summarized in the Supporting Information (SI) Text S1. The concentration of monochloramine 85 
stock solutions was chosen to get the desired concentration in the working solution. Ranitidine solutions 86 
were prepared by dissolving a pre-determined amount of ranitidine in 1 L of 10 mM acetate, phosphate 87 
or carbonate buffer. 100 mL of monochloramine stock solution was then added to the working solution 88 
and reactions were conducted in amber glass bottles at 20 °C, under dark conditions to avoid the 89 
photolysis of NDMA. At given contact times, residual oxidants were quenched using a slight excess of 90 
sodium thiosulfate (2 g/L) and samples were transferred to glass vials for HPLC-MSn analyses. Most of 91 
the experiments were performed using high initial concentrations of ranitidine in order to ensure full 92 
detection of the parent compound and its by-products. This level of concentrations was not 93 
representative of what can be detected in wastewater treatment plants or environmental samples. 94 
Total Chlorine and Chloramines Analyses. Free chlorine and total chlorine concentrations in the 95 
sodium hypochlorite stock solutions were determined by iodometric titration with sodium thiosulfate 0.1 96 
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M (Prolabo, >99.9%). NH2Cl and NHCl2 concentrations were determined by spectrophotometric 97 
measurement using their respective molar extinction coefficients at 245 nm and 295 nm and solving 98 
simultaneous equations.25 Residual oxidant was analyzed by iodometric titration. 99 
Analyses of Ranitidine and its Chloramination By-products. High performance liquid 100 
chromatography coupled with diode array detection and mass spectrometry (HPLC-DAD-MSn) analyses 101 
were performed with a Thermo Surveyor chromatographic system including two detectors: a Thermo 102 
Surveyor diode array detector and a Thermo DECA XP Plus ion trap mass spectrometer. Ranitidine and 103 
its chloramination by-products were separated using a Phenomenex Luna PFP2 column (250 × 4.6 mm, 104 
pore size: 100 Å, particle size: 5 µm). The mobile phase consisted in (A) formic acid/methanol (1:1000 105 
v/v) and (B) formic acid/milliQ water (1:1000 v/v) pumped at a flow rate of 0.6 mL/min. Elution started 106 
at 5% of A for 5 min, increased to 30% of A in 20 min and holding for 5 min, then increased to 90% of 107 
A in 10 min and holding for 2 min, and then returned to initial conditions. Total run time was 60 min 108 
(including the conditioning of the column to the initial conditions). Injection volume was 100 µL. All 109 
samples were analyzed in full scan mode and MS2 simultaneously. Chemical ionization was performed 110 
in atmospheric pressure chemical ionization mode (APCI), in positive and negative mode. The 111 
parameters were: capillary temperature of 250 °C, vaporizer temperature 450 °C, gas flow 95 u.a., 112 
auxiliary gas flow 56 u.a., corona discharge at 5 µA with a voltage 4.5 kV and capillary voltage 14 V. 113 
Mass range detection was 50-500 uma (to detect the formation of dimers). MS2 experiments were 114 
performed on protonated molecular ions in order to identify by-products. MS2 experiments were 115 
performed as follows: collision energy of 35%, Q activation of 0.25 and activation time of 30 ms. 116 
Analyses were performed in both APCI positive and APCI negative mode, but chloramination by-117 
products of ranitidine were only detected in positive mode. For the determination of ranitidine 118 
decomposition kinetics, a series of ranitidine solutions at different concentrations (ranging from 0.05 119 
µM to 2 µM) was analyzed in APCI positive mode to obtain a calibration curve (R2 = 1.000). 120 
 121 
Results and Discussion 122 
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Ranitidine Decomposition Kinetics at Several pH. The reaction of NH2Cl with ranitidine was 123 
assumed to follow second-order kinetics, first-order with respect to each reactant. The rate of ranitidine 124 
decomposition in the presence of a large excess of monochloramine ([NH2Cl]0/[RAN]0 > 100 mol/mol) 125 
can be considered as pseudo first-order with respect to ranitidine (equation 1):  126 
[RAN]k
dt
d[RAN]
obs  (1) 127 
where kobs = kapp [NH2Cl]0 128 
Ranitidine decomposition rates were determined at different pH from the reaction of 1.5 µM ranitidine 129 
with 200 µM NH2Cl, using HPLC-MS analyses. The linear plots obtained between ln([RAN]/[RAN]0) 130 
and reaction time confirmed the pseudo first-order rate with respect to the concentration of ranitidine 131 
(Figure 1). At pH < 5.5, ranitidine was instantaneously decomposed and kinetics could not be studied. 132 
Ranitidine chloramination rate decreased when increasing pH, indicating an acid-catalyzed 133 
decomposition (Figure 1). Ranitidine was found to exhibit a maximum NDMA formation yield around 134 
pH 8 after 5 days of reaction.13 However, ranitidine decomposition did not show a maximum at pH 8. 135 
This finding indicates that the higher formation of NDMA at this pH and long contact times is not 136 
directly related to the decomposition rate of molecular ranitidine. Moreover, previous work 137 
demonstrated that the formation of NDMA was very slow (maximum NDMA formation occurring after 138 
24h of contact time13) as compared to the fast decomposition rate of ranitidine observed in this study. 139 
The value of kapp at pH 7 was 34.9 M-1.s-1, which is much lower than the kinetic constants obtained for 140 
the chloramination of DMA (7.98.108  M-1.s-1)26 and resorcinol (7.5.105 M-1.s-1)23. Steric hindrance 141 
could be responsible for the slower reaction of NH2Cl with the DMA group of ranitidine as compared to 142 
DMA. Furthermore, chlorine transfer between NH2Cl and DMA is subjected to general acid 143 
catalysis.26,27 In a similar manner, chlorine transfer to the DMA group of ranitidine (i.e., electrophilic 144 
substitution) could be favored at acidic pH, which would explain the higher decomposition rate 145 
observed (Figure 1). Moreover, NH2Cl decomposes at acidic pH by disproportionation and hydrolysis 146 
and thus may create species (e.g., NHCl2 or HOCl) that enhance the decomposition of ranitidine.28 147 
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Figure 1. Ranitidine decomposition rates during chloramination at different pH. [RAN]0 = 1.5 µM, 150 
[NH2Cl]0 = 200 µM. 151 
Identification of Ranitidine By-products around Equimolar Conditions. Chromatographic and 152 
mass spectral data for ranitidine and its decomposition products analyzed by HPLC-MS are summarized 153 
in Table 1. Structures of decomposition products are proposed based on their MS and MS2 spectral data. 154 
Attempts were made to identify the reaction by-products of 5-(dimethyl-aminomethyl)furfuryl alcohol 155 
(or DFUR, a molecular structure found in ranitidine and a major precursor of NDMA10,11) but they were 156 
probably too polar to be detected in our analytical conditions. 157 
Table 1. Ranitidine reaction products detected by HPLC-MS in APCI positive mode. *By-products non-158 
detected when reactions were stopped using sodium thiosulfate. 159 
Compound 
Fragmentation 
Nominal 
mass 
Structure 
RT 
(min) 
Ranitidine (RAN) 315, 270 (4 %), 176 (1.6%), 
111 (2%) 
314 
O
S
H
N
NO2
H
N
N
 
24.1 
NDMA 
75 74 
 
16.0 
Dimethyl-aminomethyl furfuryl 
alcohol (DFUR) 156, 111 (38%) 155 
 
8.0 
 
8 
thioethyl-N-methyl-2-nitroethene-
1,1-diamine (P175) 
176, 145 (10%), 130 (6%), 
116 (4%) 
175 
 
16.6 
RAN + NH2 (P330) 
330, 270 (5%), 113 (8%) 330 
O
S
H
N
NO2
H
N
N
NH2
 
22.7 
RAN + NH2 + Cl (P364) 364 (366), 304 (6%, 306), 
223 (4%), 95 (4%) 
364 
O
S
H
N
NO2
H
N Cl
N
NH2
 
22.1 
RAN + Cl (P348) 349 (351), 304 (3%), 223 
(7%), 170 (3%) 
348 
x=1 : m/z 349, x=2 : m/z 383
O
S
H
N
NO2
H
N x Cl
N
 
24.8 
RAN + 2 Cl (P382) * 383 (385, 387), 349 (6%, 
351), 170 (19%), 111 (10%) 
382 
38.8 
RAN + OH 331, 286 (7%), 193 (29%), 
154 (22%), 111 (34%) 
330 
x=0 : m/z 331
x=1 : m/z 365
x=2 : m/z 399
O
S
H
N
NO2
H
N OH, x Cl
N
 
12.7 
RAN + OH + Cl 
365 (367), 227 (19%, 229), 
181 (49%), 154 (32%), 111 
(52%) 
364 
11.4 
RAN + OH + 2 Cl * 
399 (401,403), 270, 215 
(217), 167 (169), 154, 139, 
111 
398 
40.0 
P175 + OH (P191) 
192 191 
x=1, y=0 : m/z 192
x=2, y=1 : m/z 242
x=2, y=3 : m/z 310
S
H
N
NO2
H
N x OH, y Cl
 
17.2 
P175 + 2 OH + Cl (P241) 
242 (244), 192 (9%) 241 
39.6 
P175 + 2 OH + 3 Cl 310 (312, 314), 192 (9%), 
181 (13%), 145 (8%) 
309 
24.4 
RAN - DMA + 2 OH + Cl (P337) 
338 (340), 320 (12%), 259 
(37%), 227 (31%), 192 
(41%), 181 (86%), 111 
(154%) 
337 
x=1 : m/z 338, x=2 : m/z 354
O
S
H
N
NO2
H
N Cl, x OH
HO
 
23.9 
RAN - DMA + 3 OH + Cl (P353) 
354 (356), 259 (10%), 249 
(53%), 185 (22%), 152 
(14%), 111 (17%) 
353 
26.5 
 160 
 161 
Ranitidine and monochloramine were introduced in the reaction buffer at 167 µM and 400 µM, 162 
respectively (similar concentration range), to identify the first compounds produced by ranitidine 163 
decomposition in the presence of low concentrations of NH2Cl. Major ions produced were chlorinated 164 
and/or hydroxylated derivatives, i.e., m/z 331 (hydroxylated ranitidine), m/z 349 (chlorinated ranitidine), 165 
m/z 365 (chlorinated and hydroxylated ranitidine), m/z 383 (ranitidine with two chlorine atoms) and m/z 166 
399 (hydroxylated ranitidine with two chlorine atoms) (see SI, Figure S1). These products can result 167 
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from chlorination and further oxidation of the N-methyl-2-nitroethene-1,1-diamine group. As proposed 168 
by Joo and Mitch for the chloramination of monomethylamine, chlorine attack on nitrogen atom and 169 
oxidation leads to the formation of organic chloramines and hydroxylamines.29 The presence of m/z 399 170 
can be attributed to the subsequent chlorine substitution on N-methyl or ethene double bond or on the 171 
sulfur atom. Some other by-products were detected in smaller amounts. Experiments were carried out 172 
without quenching residual oxidant at the desired reaction time in order to investigate the potential 173 
influence of sodium thiosulfate on the by-products stability, because sodium thiosulfate can break N-Cl 174 
bonds formed after chlorination.30 Only products containing two chlorine atoms (i.e., molecular ions m/z 175 
383 and m/z 399) were not detected when sodium thiosulfate was added. All the other by-products were 176 
detected with and without sodium thiosulfate addition. MS2 experiments were conducted on ranitidine 177 
and the above-mentioned by-products to determine the position of chlorine substitution and 178 
hydroxylation. Figure S2a in SI gives the MS2 spectrum obtained for ranitidine. A loss of dimethylamine 179 
(DMA) group (45 Da) gave the fragment ion m/z 270, and the following loss of NO2 radical ion (46 Da) 180 
generated the radical fragment ion m/z 224. Different ruptures of C-S bonds led to the formation of 181 
fragments m/z 176, 144 and 124. These results are in accordance with MS2 fragments observed in a 182 
previous study by Radjenović et al.,31 using a quadrupole-time of flight (Q-Tof) detection. In the same 183 
study, the compound with molecular ion m/z 331 has been identified as a photocatalytic by-product of 184 
ranitidine.31 The difference of 16 Da was attributed to the hydroxylation of ranitidine. MS2 experiments 185 
on this molecular ion revealed similar fragments than those observed by Radjenović et al.31 (See SI, 186 
Figure S3b). The typical loss of DMA group led to the fragment m/z 286 and further loss of water led to 187 
the fragment m/z 268, which confirms the hydroxylation of ranitidine. Different ruptures of C-S bonds 188 
in the molecular ion m/z 331 generated pairs of fragments m/z 156 and 176, and fragments m/z 188 and 189 
143. Fragment ion m/z 156 can be attributed to the previously mentioned DFUR, i.e. the hydroxylated 190 
dimethylaminomethylfuran group. Dehydroxylation of DFUR led to the fragment m/z 138 (Figure S3). 191 
By comparing the MS2 fragments of chlorinated ranitidine (m/z 349) with that of ranitidine (m/z 315), 192 
several similarities could be observed (see SI, Figure S2). Losses of DMA and NO2 groups from 193 
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chlorinated ranitidine generated chlorinated fragments m/z 304 and 258. This indicates that chlorine 194 
transfer did not occur on the dimethylamino group as it was previously suggested during chloramination 195 
of tertiary amines.32 This implies that chlorine transfer leading to the release of DMA is not a pathway 196 
of NDMA formation by chloramination of ranitidine. Moreover, the major fragment ion of chlorinated 197 
ranitidine was m/z 210. This fragment is the chlorinated analogue of the fragment ion m/z 176 of 198 
ranitidine, which indicates that chlorine substitution does not occur on the furan group but probably on 199 
nitrogen or sulfur atoms. This is confirmed by the fact that a chlorinated analogue of m/z 124 (i.e. the 200 
dimethylaminomethylfuran fragment) was not detected. 201 
Some minor by-products exhibited a gain of 15 Da as compared to molecular ranitidine and 202 
chlorinated ranitidine. Chromatograms exhibited small peaks with a molecular ion m/z 330 203 
(intermediate product P330) and a molecular ion m/z 364 (P364) at retention times of 22.7 min and 22.1 204 
min, respectively. P364 was identified as the chlorinated analogue of P330. The observation of such 205 
products is consistent with the occurrence of a nucleophilic substitution between NH2 group of 206 
monochloramine and the DMA group of ranitidine, leading to a gain of 15 Da as compared to ranitidine 207 
(i.e. P330) (Scheme 1). Moreover, the odd nominal mass of this product indicates an odd number of 208 
nitrogen atoms, confirming the gain of a nitrogen atom as compared to ranitidine. The relatively low 209 
abundance of this peak suggests that it is rapidly decomposed to other degradation by-products. MS2 210 
experiment conducted on P330 generated the same fragments as ranitidine (i.e., m/z 270, 258, 224, 176 211 
and 124, Figure S3). This indicates that the fragmentation of P330 leads to the loss of the NH2 group, 212 
probably because of a weak bond. MS2 fragmentation of the chlorinated analogue of P330 did not 213 
provide any additional information. 214 
 215 
Influence of NH2Cl Concentration. The reaction between ranitidine (167 µM) and various 216 
concentrations of NH2Cl (ranging from 0 to 1 mM) after 2h of reaction time at pH 8 (with 10 mM 217 
phosphate buffer) was monitored using HPLC-MS (Figure 2). Decomposition rate of ranitidine 218 
increased with increasing NH2Cl concentration until full degradation for concentrations greater than 0.5 219 
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mM. The formation of chlorinated ranitidine (i.e., m/z 349) decreased with increasing NH2Cl 220 
concentration. Maximum chlorinated ranitidine formation occurred when ranitidine and NH2Cl were 221 
introduced in equimolar concentrations. 222 
Most of the major by-products were preferentially formed for a NH2Cl/ranitidine ratio of 223 
approximately 2 mol/mol (e.g., m/z 176, 192, 330, 331, 364, 365) (Figure 2). By-products with 224 
molecular ions m/z 176 (P175) and m/z 192 (P191) were detected at retention times of 16.6 min and 225 
17.2 min respectively. P191 was identified as the hydroxylated analogue of P175 (i.e. the thioethyl-N-226 
methyl-2-nitroethene-1,1-diamine moiety). NDMA formation occurred only for a NH2Cl concentration 227 
of 1 mM, i.e. in a large excess of NH2Cl, and after disappearance of the other by-products. Products 228 
P330 and P364 (postulated as resulting from nucleophilic substitution on the DMA group of ranitidine) 229 
were totally degraded at NH2Cl concentrations where NDMA formed (i.e., 1 mM), observation 230 
consistent with their potential implication as intermediate compounds involved in the formation of 231 
NDMA. 232 
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Figure 2. Influence of NH2Cl concentration on the decomposition of ranitidine and the formation of 234 
ranitidine by-products. [RAN]0 = 167 µM, t = 2 h, pH = 8. Relative scale based on initial ranitidine 235 
concentration. 236 
Ranitidine By-products Formed in Excess of Monochloramine. In order to determine the by-237 
products formed in the presence of an excess of monochloramine, i.e. in the conditions where NDMA 238 
formation is favored, the decomposition of ranitidine (12 µM) was investigated in the presence of 2.5 239 
mM NH2Cl over 48 h at pH 8 (with 10 mM phosphate buffer). These conditions have been 240 
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demonstrated to maximize the formation of NDMA.13 Decomposition of ranitidine was complete in less 241 
than 2 min, while the formation of NDMA was much slower (Figure 3a). Chlorine transfer (i.e., the 242 
formation of chlorinated ranitidine) was very fast and chlorinated ranitidine was entirely decomposed in 243 
less than 2 min as well as ranitidine. NDMA formation reached a plateau after 75 min. This is in 244 
agreement with our previous observations of NDMA formation in similar conditions and monitored by 245 
GC/MS.13 Products that were previously detected when NH2Cl was introduced at equimolar 246 
concentrations or with a slight excess as compared to ranitidine (e.g., fragments m/z 156, 330, 331, 364, 247 
365, Figure 2) were not detected, probably because they were rapidly decomposed in the presence of a 248 
large excess of NH2Cl (Figure 3b). 249  
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Figure 3. Decomposition of ranitidine (a) and formation of NDMA and other by-products (a and b) by 251 
chloramination monitored by HPLC-MS in APCI positive mode. [RAN]0 = 12 µM; [NH2Cl]0 = 2.5 mM; 252 
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pH = 8 with 10 mM phosphate  buffer. Relative area is based on initial ranitidine concentration. Solid 253 
line (a) represents model values of ranitidine decomposition based on the rate constant obtained at pH 8. 254 
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Figure 4. Formation of NDMA and other by-products by chloramination of ranitidine monitored by 257 
HPLC-MS in APCI positive mode. [RAN]0 = 120 µM; [NH2Cl]0 = 10 mM; pH = 8. Lines represent best 258 
fits of data. 259 
Figure 4 depicts the formation of ranitidine by-products for higher initial concentrations (i.e., 120 μM 260 
of ranitidine and 10 mM of NH2Cl) and longer contact times. Different products were slowly formed 261 
along with NDMA (m/z 111, 242, 310, and 354). NDMA (m/z = 75) and products with molecular ions 262 
m/z 242 and m/z 310 reached a plateau after 30 min of contact time. The product with a molecular ion 263 
m/z 242 (P241) was generated by hydroxylation and chlorination of P175, probably on nitrogen atoms 264 
of the N-methyl-2-nitroethene-1,1-diamine moiety as previously mentioned for molecular ranitidine. 265 
Subsequent chlorination of P241 led to the product with a molecular ion m/z 310 (the presence of 3 266 
chlorine atoms was confirmed by its isotopic distribution). 267 
The ion m/z 111 was identified as the major fragment of the molecular ion m/z 338 (P337) (see Table 268 
1). The odd nominal mass of this product indicates an odd number of nitrogen atoms, reflecting the loss 269 
of the DMA group. MS spectra of this product revealed the presence of a chlorine atom and a gain of 32 270 
Da. This molecule can be attributed to the dihydroxylation and chlorination of ranitidine after the loss of 271 
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the DMA group (corresponding to fragment m/z 270). The product with molecular ion m/z 354 (P353) 272 
was identified as a hydroxylated analogue of P337, thus explaining the short delay between the 273 
formations of these products (Figure 4). P337 and P353 reached a maximum after around 1 h of reaction 274 
and then slowly decreased. Their formation was strongly correlated to NDMA formation during the first 275 
45 min of reaction. Hence, these compounds may be products resulting from carbocation intermediates 276 
formed during the last step of NDMA formation, as discussed below. 277 
 278 
Influence of Free Chlorine. The influence of free chlorine (180 µM HOCl) on ranitidine (180 µM) was 279 
investigated to compare chlorination and chloramination by-products produced at pH 8 and after 2 h of 280 
contact time. Similar chlorinated and hydroxylated by-products (i.e., molecular ions m/z 156, 176, 192, 281 
331, 349, 365) were formed after chlorination and chloramination and exhibited similar responses. 282 
However, P330 and P364 (chlorinated analogue of P330) were not detected in the presence of HOCl. 283 
This confirms the hypothesis of a nucleophilic substitution between NH2Cl and the DMA group of 284 
ranitidine, leading to the P330 intermediate. Subsequent electrophilic substitution of P330 gives the 285 
chlorinated analogue P364. 286 
 287 
Proposed NDMA Formation Pathway 288 
During chloramination of amines, either chlorine transfer or nucleophilic substitution can occur. 289 
Chlorine transfer from NH2Cl to the nitrogen atom of the DMA group of ranitidine is unlikely to occur 290 
as a predominant pathway because it would only lead to the formation of DMA or dimethylchloramine 291 
(DMCA) that are minor precursors of NDMA (i.e., < 3% molar yields).2,6,7 Several tertiary amines have 292 
been demonstrated to produce important yields of NDMA, especially ranitidine (> 60% molar yield),11-13 293 
and more recently dimethylbenzylamine (64% molar yield).17 Hence, a chlorine transfer (i.e., 294 
electrophilic substitution) cannot explain the high yields of NDMA obtained for those tertiary amines. 295 
The formation of NDMA by chloramination of DMA was previously proposed to occur via the 296 
formation of an UDMH, UDMH-Cl or UDMH-Br intermediate, followed by an oxidation in the 297 
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presence of dissolved oxygen.6,7,9,10 This last step of the mechanism remains quite unclear because the 298 
kinetics of UDMH oxidation have not been clearly investigated in the presence of both dissolved oxygen 299 
and NH2Cl. UDMH (m/z 61) or equivalent intermediates UDMH-Cl (m/z 95) and UDMH-Br (m/z 139) 300 
were not detected in our analysis conditions. They were probably not separated correctly by liquid 301 
chromatography because of their low molecular weight. Moreover, they are expected to be rapidly 302 
oxidized to NDMA in the presence of dissolved oxygen and monochloramine or free chlorine, which 303 
explains why they have never been observed when NDMA was formed during chlorination or 304 
chloramination of water solutions containing amines.7,8 Experiments were conducted to investigate the 305 
formation of NDMA by oxidation of UDMH (500 nM) by NH2Cl (2.5 mM) in the presence of dissolved 306 
oxygen. Molar yields after 24h of contact time were very low (i.e., < 0.01 %) as compared to NDMA 307 
formation from ranitidine (i.e., > 60%). Our results are in accordance with several studies that 308 
investigated UDMH oxidation by dissolved oxygen or NH2Cl.33-35 Hence, these results suggest that 309 
UDMH is not likely to be a major intermediate involved in the formation of NDMA during 310 
chloramination, especially from tertiary amines such as ranitidine.  311 
Based on these observations, we propose that DMA groups must be attached at the benzylic position 312 
of aromatic or heterocyclic rings in order to produce high yields of NDMA. Indeed, as shown in Scheme 313 
1, the release of NDMA from ranitidine leads to the formation of a stable carbocation at benzylic 314 
position of the furan ring that is favored thermodynamically. These carbocation intermediates are prone 315 
to react with nucleophiles such as water and thus may lead to the observed products P337 and P353 after 316 
hydroxylation on the methylene group. This mechanism is in accordance with the simultaneous 317 
production of P337, P353 and NDMA observed during chloramination of ranitidine (Figure 4). 318 
In a previous study, we demonstrated that almost no NDMA was formed in the absence of dissolved 319 
oxygen during chloramination of ranitidine.13 Because the formation of UDMH and its oxidation by 320 
dissolved oxygen is not likely to occur, dissolved oxygen incorporation has to occur directly on the 321 
intermediate formed after the reaction between NH2Cl and the DMA group of ranitidine (i.e. products 322 
P330 or P364). Hence, we propose that the positive charge on the nitrogen atom of the DMA moiety 323 
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reduces the pKa of hydrogen on the NH2 group, therefore favoring the formation of a highly reactive 324 
NH- intermediate which reacts with dissolved oxygen to yield a NDMA precursor group. 325 
We hypothesize that nucleophilic substitution rather than chlorine transfer is the main reaction 326 
occurring on the DMA moiety of ranitidine. In this case the steric hindrance brought by the two methyl 327 
groups probably disfavors the transfer of the bulky chlorine atom of NH2Cl to the amine.  However, 328 
chlorine transfer is likely to take place on less hindered moieties of ranitidine, especially on nitrogen 329 
atoms of the thioethyl-N-methyl-2-nitroethene-1,1-diamine moiety, producing the chlorinated analogues 330 
of ranitidine (i.e., m/z 349 and m/z 383) and then hydroxylated analogues after further oxidation. 331 
Chlorine transfer can also take place on the sulfur atom and cause sulfoxide compounds formation,36 or 332 
the cleavage of the C-S bond leading to the release of the observed product P175 and 333 
5-(dimethylaminomethyl)furfuryl alcohol (DFUR, m/z 156) (see SI, Scheme S1). Our results are 334 
consistent with three initial reactions: i) fast chlorine transfer leading to chlorinated analogues of 335 
ranitidine, ii) the cleavage of the C-S bond leading to DFUR and iii) nucleophilic substitution leading to 336 
P330. The proposed pathways are also probably interconnected because chlorinated ranitidine (P348) 337 
can also react with NH2Cl through nucleophilic substitution and lead to P364, and both hydroxylated 338 
and chlorinated ranitidine analogues can liberate DFUR through the cleavage of C-S bond. DFUR is 339 
known to be a decomposition product of ranitidine,37 and to produce important amounts of NDMA as 340 
well as ranitidine (i.e., > 50% molar yields).10,11 Hence, DFUR produced via chlorine addition on 341 
ranitidine and C-S bond cleavage could react with NH2Cl to contribute to the overall formation of 342 
NDMA. The stable carbocation (i.e. methylfurfuryl alcohol) that would form along with NDMA via this 343 
pathway and its hydroxylated analogue were not detected, probably because they were not properly 344 
separated in our chromatographic conditions. 345 
 346 
 347 
Scheme 1. NDMA formation mechanism proposed for the chloramination of ranitidine (N.D. = Not 348 
Detected). 349 
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Implications for Water Treatment 352 
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The kinetics study revealed that ranitidine decomposition was favored at acidic pH, while NDMA 353 
formation reaches a maximum around pH 8.13 Hence, NDMA formation cannot be directly related to the 354 
decomposition of molecular ranitidine. The influence of pH on NDMA formation depends on complex 355 
reactions involving monochloramine stability, the potential formation of chloramines decomposition 356 
products (e.g., peroxynitrite ions or hydrazine intermediates), or acid dissociation constants of ranitidine 357 
and its by-products. Even if the disproportionation of NH2Cl to NHCl2 has been proposed to favor the 358 
formation of NDMA from the reaction with DMA,8 the decomposition of NH2Cl at acidic pH is 359 
expected to limit the production of NDMA in the case of ranitidine oxidation.13 Moreover, no analogue 360 
to P330 with a chlorine atom on the amine group (i.e., RAN + NHCl) was detected, as it could be 361 
expected to form from the reaction of ranitidine with dichloramine. In our experimental conditions (i.e., 362 
pH 8), the production of NHCl2 was limited. Hence, NHCl2 does not seem to play a major role in the 363 
formation of NDMA during chloramination of ranitidine, as we already proposed in a previous study.13 364 
Chlorine transfer between NH2Cl and DMA is also subjected to general acid catalysis.25,27 In a similar 365 
manner, chlorine transfer to the DMA group of ranitidine (i.e., electrophilic substitution) could be 366 
favored at acidic pH, which would explain the higher decomposition rate observed (Figure 1), and thus 367 
would limit the occurrence of a nucleophilic substitution and subsequent NDMA formation. Hence, the 368 
formation of NDMA from ranitidine during water treatment processes could be reduced by favoring 369 
electrophilic substitution (i.e., chlorine attack) at pH < 7. 370 
Many by-products were identified during the chloramination of ranitidine. Different compounds are 371 
produced depending on NH2Cl:ranitidine ratio and reaction time. Nucleophilic substitution of DMA 372 
group is not affected by C-S bond cleavage and formation of chlorinated and hydroxylated analogues of 373 
ranitidine. Thus NDMA formation occurs through multiple pathways, which explains the high yields 374 
observed. In real water disinfection conditions, ranitidine (or another major precursor of NDMA) is 375 
expected to be at very low concentrations (i.e. at ng/L levels) as compared to NH2Cl concentrations. 376 
Hence, NDMA formation from ranitidine is likely to be maximized in these conditions and could only 377 
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be limited by lowering the pH or by reducing the initial concentration of ranitidine (or other NDMA 378 
precursors). 379 
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